The Value of Cancer Treatment Today
In recent decades, tremendous progress has been made in the fight against cancer. Continued research has expanded our knowledge of how the disease develops and how to target medicines for specific cancer types – resulting in more effective therapies for patients. Biopharmaceutical companies are developing 836 medicines and vaccines for cancer, all of which are in clinical trials or awaiting review by the U.S. Food and Drug Administration (FDA).
Biopharmaceutical innovation and new drug discovery delivers far-reaching benefits to patients, the U.S. health care system and our state and national economies. New cancer medicines discovered and developed by America’s biopharmaceutical research companies are helping patients lead longer, more productive lives, controlling healthcare costs and stimulating the economy through high-quality jobs and a healthier workforce.
Key Facts About Cancer
- The cancer death rate has fallen 23% from its peak in 1991, in large part due to medicines.
- Survival rates for childhood cancers have increased 43% over the last several decades.
- 73% of cancer medicines in the pipeline have the potential to be personalized medicines.
- More than 23 million years of collective life have been saved through cancer treatment advances between 1988 and 2000.
- The value of cancer treatment between 1988 and 2000 amounted to $1.9 trillion - learn more about its impact.